Atlas Trials

Theranova Randomized, Controlled, Trial (RCT) in China

Clinical trial NCT05309291 · COMPLETED

Trial details

NCT number
NCT05309291
Sponsor
Vantive Health LLC
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Kidney FailureAcute Kidney Failure
Start date
2022-06-22
Primary completion
2023-07-06
Enrollment
323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.